Clinical Trials Sponsored by Allos Therapeutics
Total 6348 results
-
ONL TherapeuticsCompletedRhegmatogenous Retinal Detachment - Macula OffAustralia
-
Akebia TherapeuticsCompletedAnemia | Dialysis-dependent Chronic Kidney DiseaseUnited States
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Amnis TherapeuticsTerminatedIschemic StrokeSpain, Sweden
-
Elevar TherapeuticsCompletedGastric Cancer | Gastric AdenocarcinomaUnited States, United Kingdom, Korea, Republic of, France, Taiwan, Japan, Russian Federation, Germany, Italy, Poland, Romania, Ukraine
-
Sage TherapeuticsCompleted
-
Nektar TherapeuticsTerminatedMelanoma | Sarcoma | Renal Cell Carcinoma | Colorectal Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Merkel Cell CarcinomaUnited States
-
Akebia TherapeuticsCompletedAnemia | Dialysis-Dependent Chronic Kidney DiseaseUnited States, Italy, Canada, Korea, Republic of, United Kingdom, Australia, Germany, Israel, France, Portugal, Bulgaria, Russian Federation, Ukraine, Poland, Brazil, Argentina, Mexico, Serbia
-
PTC TherapeuticsTerminatedLimb-Girdle Muscular DystrophyUnited States, Norway, Canada, Sweden, Russian Federation, Denmark, France, Germany
-
Akebia TherapeuticsCompletedAnemia | Non-Dialysis-Dependent Chronic Kidney DiseaseUnited States, Italy, Spain, Czechia, Korea, Republic of, Malaysia, Australia, New Zealand, United Kingdom, Germany, Turkey, Ukraine, France, Hungary, Austria, Israel, Bulgaria, Russian Federation, Romania, Slovakia, South Africa, Canad... and more
-
Aprea TherapeuticsCompletedGastric Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Urothelial CarcinomaUnited States
-
ProQR TherapeuticsActive, not recruitingEye Diseases | Retinitis | Eye Diseases, Hereditary | Retinal Dystrophies | Vision Disorders | Retinal Disease | Autosomal Dominant Retinitis Pigmentosa | Vision TunnelUnited States
-
Sage TherapeuticsCompletedSuper-refractory Status EpilepticusUnited States
-
Amicus TherapeuticsTerminatedBatten Disease | Neuronal Ceroid Lipofuscinosis CLN6 | Neuronal Ceroid Lipofuscinosis CLN3United States
-
Intrinsic TherapeuticsCompletedLumbar Disc Herniation
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
Sangamo TherapeuticsTerminated
-
ProQR TherapeuticsActive, not recruitingEye Diseases | Neurologic Manifestations | Eye Diseases, Hereditary | Sensation Disorders | Vision Disorders | Blindness | Leber Congenital Amaurosis | Leber Congenital Amaurosis 10 | Retinal Disease | Eye Disorders CongenitalUnited States, Belgium, Brazil, Canada, France, Germany, Italy, Netherlands, United Kingdom
-
Aligos TherapeuticsTerminatedChronic Hepatitis BKorea, Republic of, China, Hong Kong, United Kingdom, New Zealand, Moldova, Republic of
-
Cartesian TherapeuticsCompletedMultiple MyelomaUnited States
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
Heron TherapeuticsCompleted
-
Sage TherapeuticsCompleted
-
Sage TherapeuticsCompleted
-
Sage TherapeuticsCompletedPostpartum DepressionUnited States
-
Sage TherapeuticsCompletedSuper-Refractory Status EpilepticusUnited States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Serbia, Spain, Sweden, United Kingdom
-
Sage TherapeuticsCompletedPostpartum DepressionUnited States
-
Amicus TherapeuticsCompletedVariant Late-Infantile Neuronal Ceroid LipofuscinosisUnited States
-
Celldex TherapeuticsCompleted
-
Sage TherapeuticsCompleted
-
Halozyme TherapeuticsCompletedDermatitis, Allergic ContactUnited States
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Fate TherapeuticsTerminatedHematologic MalignanciesUnited States
-
Fate TherapeuticsCompletedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | HER2 Positive Gastric Cancer | EGFR Positive Solid TumorUnited States
-
Fulcrum TherapeuticsCompletedHealthy Adult SubjectsUnited States
-
Blade TherapeuticsCompletedRelative BioavailabilityAustralia
-
Heron TherapeuticsCompleted
-
Halozyme TherapeuticsCompleted
-
TR TherapeuticsCompleted
-
Heron TherapeuticsCompleted
-
Heron TherapeuticsCompletedPostoperative PainUnited States, Belgium
-
Heron TherapeuticsCompleted
-
Causeway TherapeuticsCompletedTennis ElbowUnited Kingdom
-
Corcept TherapeuticsCompleted
-
UNION therapeuticsCompleted
-
Phoenicis TherapeuticsTerminatedEpidermolysis Bullosa Dystrophica, Recessive | Epidermolysis Bullosa Dystrophica, DominantUnited States, Spain, France
-
Allergy TherapeuticsWithdrawnType I HypersensitivityCanada
-
Cadent TherapeuticsCompleted
-
Nektar TherapeuticsCompletedColorectal CancerUnited States, Belgium, Germany, India, Spain, United Kingdom
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States